{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:12:51Z","timestamp":1778083971933,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["754517"],"award-info":[{"award-number":["754517"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.hjc.2025.07.004","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:51:05Z","timestamp":1753116665000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ischemic stroke in patients with atrial fibrillation on oral anticoagulants: characteristics and long-term outcomes"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-8316","authenticated-orcid":false,"given":"Eleni","family":"Korompoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0629-9248","authenticated-orcid":false,"given":"George","family":"Ntaios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Sagris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Vemmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hjc.2025.07.004_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S1474-4422(10)70274-X","article-title":"Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial","volume":"9","author":"Diener","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.hjc.2025.07.004_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","article-title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.hjc.2025.07.004_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(12)70092-3","article-title":"Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial","volume":"11","author":"Easton","year":"2012","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.hjc.2025.07.004_bib4","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/STROKEAHA.116.013540","article-title":"Outcomes with edoxaban versus warfarin in patients with previous cerebrovascular events: findings from ENGAGE AF-TIMI 48 (effective anticoagulation with factor xa next generation in atrial fibrillation-thrombolysis in myocardial infarction 48)","volume":"47","author":"Rost","year":"2016","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.hjc.2025.07.004_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses","volume":"39","author":"Almutairi","year":"2017","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.hjc.2025.07.004_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2459\/JCM.0000000000001226","article-title":"Indications for percutaneous left atrial appendage occlusion in hospitalized patients with atrial fibrillation","volume":"23","author":"Vrana","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"10.1016\/j.hjc.2025.07.004_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.hjc.2025.07.004_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/ane.13552","article-title":"Ischemic stroke in oral anticoagulated patients with atrial fibrillation","volume":"145","author":"D\u2019Anna","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.hjc.2025.07.004_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.25700","article-title":"Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"87","author":"Seiffge","year":"2020","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.hjc.2025.07.004_bib10","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1161\/STROKEAHA.109.562769","article-title":"Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants","volume":"40","author":"Rizos","year":"2009","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.hjc.2025.07.004_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000016042","article-title":"The Athens stroke registry: results of a five-year hospital-based study","volume":"10","author":"Vemmos","year":"2000","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.hjc.2025.07.004_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.hjc.2025.07.004_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.hjc.2025.07.004_bib14","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","article-title":"Improving the assessment of outcomes in stroke. Use of a structured interview to assign grades on the modified Rankin Scale","volume":"33","author":"Wilson","year":"2002","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.hjc.2025.07.004_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/STROKEAHA.114.007852","article-title":"Rates of ischemic stroke during warfarin treatment for atrial fibrillation","volume":"46","author":"Tung","year":"2015","journal-title":"Stroke"},{"issue":"9065","key":"10.1016\/j.hjc.2025.07.004_bib16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hjc.2025.07.004_bib17","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/hs1001.097093","article-title":"Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial","volume":"32","author":"Saxena","year":"2001","journal-title":"Stroke"},{"issue":"8882","key":"10.1016\/j.hjc.2025.07.004_bib18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group","volume":"342","year":"1993","journal-title":"Lancet"},{"issue":"6867","key":"10.1016\/j.hjc.2025.07.004_bib19","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/bmj.305.6867.1460","article-title":"Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)","volume":"305","author":"Sandercock","year":"1992","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.hjc.2025.07.004_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.STR.0000072985.24967.7F","article-title":"Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register","volume":"34","author":"Hillen","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.hjc.2025.07.004_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/STROKEAHA.119.027275","article-title":"Atrial fibrillation-associated ischemic stroke patients with prior anticoagulation have higher risk for recurrent stroke","volume":"51","author":"Tanaka","year":"2020","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.hjc.2025.07.004_bib22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.hjc.2025.07.004_bib23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp-2020-323963","article-title":"Ischaemic stroke in anticoagulated patients with atrial fibrillation","volume":"92","author":"Stretz","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.hjc.2025.07.004_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11239-016-1430-8","article-title":"Continuation of direct oral anticoagulants in the acute phase of ischemic stroke. A case series","volume":"43","author":"Cappellari","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"10.1016\/j.hjc.2025.07.004_bib25","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/ene.13405","article-title":"The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation","volume":"24","author":"Sakamoto","year":"2017","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.hjc.2025.07.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092938","article-title":"Etiology of ischemic strokes of patients with atrial fibrillation and therapy with anticoagulants","volume":"9","author":"Purrucker","year":"2020","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.hjc.2025.07.004_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/ijs.12150","article-title":"Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial","volume":"9","author":"Toni","year":"2014","journal-title":"Int J Stroke"},{"issue":"5","key":"10.1016\/j.hjc.2025.07.004_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hjc.2025.07.004_bib29","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hjc.2025.07.004_bib30","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"10117","key":"10.1016\/j.hjc.2025.07.004_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.hjc.2025.07.004_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.recesp.2019.02.018","article-title":"Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry","volume":"73","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"Rev Esp Cardiol"},{"issue":"25","key":"10.1016\/j.hjc.2025.07.004_bib33","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hjc.2025.07.004_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11886-020-01388-w","article-title":"Permanent bilateral carotid filters for stroke prevention in atrial fibrillation","volume":"22","author":"De Potter","year":"2020","journal-title":"Curr Cardiol Rep"},{"issue":"7","key":"10.1016\/j.hjc.2025.07.004_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jacc.2019.04.035","article-title":"Permanent percutaneous carotid artery filter to prevent stroke in atrial fibrillation patients: the CAPTURE trial","volume":"74","author":"Reddy","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966625001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966625001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:24:22Z","timestamp":1772882662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966625001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"alternative-id":["S1109966625001794"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2025.07.004","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic stroke in patients with atrial fibrillation on oral anticoagulants: characteristics and long-term outcomes","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2025.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}